UTHR United Therapeutics Corporation

USD 359.58 0.00 ( 0.00)%
Icon

United Therapeutics Corporation (UTHR) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 359.58

0.00 (0.00)%

USD 16.18B

1.01M

USD 379.76(+5.61%)

USD 214.00 (-40.49%)

Icon

UTHR

United Therapeutics Corporation (USD)
COMMON STOCK | NSD
USD 359.58
0.00 ( 0.00)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 16.18B

USD 214.00 (-40.49%)

USD 359.58

United Therapeutics Corporation (UTHR) Stock Forecast

Show ratings and price targets of :
USD 379.76
(+5.61%)

Based on the United Therapeutics Corporation stock forecast from 10 analysts, the average analyst target price for United Therapeutics Corporation is USD 379.76 over the next 12 months. United Therapeutics Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of United Therapeutics Corporation is Slightly Bullish , which is based on 10 positive signals and 5 negative signals. At the last closing, United Therapeutics Corporation’s stock price was USD 359.58. United Therapeutics Corporation’s stock price has changed by -0.62% over the past week, -3.57% over the past month and +64.24% over the last year.

No recent analyst target price found for United Therapeutics Corporation
No recent average analyst rating found for United Therapeutics Corporation

Company Overview United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI...Read More

https://www.unither.com

1000 Spring Street, Silver Spring, MD, United States, 20910

1,168

December

USD

USA

Adjusted Closing Price for United Therapeutics Corporation (UTHR)

Loading...

Unadjusted Closing Price for United Therapeutics Corporation (UTHR)

Loading...

Share Trading Volume for United Therapeutics Corporation Shares

Loading...

Compare Performance of United Therapeutics Corporation Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for UTHR

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To United Therapeutics Corporation (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD120.60B 32.57 223.64

Frequently Asked Questions About United Therapeutics Corporation (UTHR) Stock

Based on ratings from 10 analysts United Therapeutics Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 12 buy, 1 sell and 4 hold ratings.

Unfortunately we do not have enough data on UTHR's stock to indicate if its a good dividend stock.

Based on targets from 10 analysts, the average taret price for UTHR is USD 379.76 over the next 12 months. The maximum analyst target price is USD 575 while the minimum anlayst target price is USD 280.

UTHR stock's Price/Earning ratio is 15.90. Our analysis grades UTHR stock's Price / Earning ratio at F. This means that UTHR stock's Price/Earning ratio is above 67% of the stocks in the Biotechnology sector in the NSD exchange. Based on this UTHR may be a overvalued for its sector.

The last closing price of UTHR's stock was USD 359.58.

The most recent market capitalization for UTHR is USD 16.18B.

Based on targets from 10 analysts, the average taret price for UTHR is projected at USD 379.76 over the next 12 months. This means that UTHR's stock price may go up by +5.61% over the next 12 months.

We can't find any ETFs which contains United Therapeutics Corporation's stock.

As per our most recent records United Therapeutics Corporation has 1,168 Employees.

United Therapeutics Corporation's registered address is 1000 Spring Street, Silver Spring, MD, United States, 20910. You can get more information about it from United Therapeutics Corporation's website at https://www.unither.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About United Therapeutics Corporation (UTHR) Stock

Based on ratings from 10 analysts United Therapeutics Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 12 buy, 1 sell and 4 hold ratings.

Unfortunately we do not have enough data on UTHR's stock to indicate if its a good dividend stock.

Based on targets from 10 analysts, the average taret price for UTHR is USD 379.76 over the next 12 months. The maximum analyst target price is USD 575 while the minimum anlayst target price is USD 280.

UTHR stock's Price/Earning ratio is 15.90. Our analysis grades UTHR stock's Price / Earning ratio at F. This means that UTHR stock's Price/Earning ratio is above 67% of the stocks in the Biotechnology sector in the NSD exchange. Based on this UTHR may be a overvalued for its sector.

The last closing price of UTHR's stock was USD 359.58.

The most recent market capitalization for UTHR is USD 16.18B.

Based on targets from 10 analysts, the average taret price for UTHR is projected at USD 379.76 over the next 12 months. This means that UTHR's stock price may go up by +5.61% over the next 12 months.

We can't find any ETFs which contains United Therapeutics Corporation's stock.

As per our most recent records United Therapeutics Corporation has 1,168 Employees.

United Therapeutics Corporation's registered address is 1000 Spring Street, Silver Spring, MD, United States, 20910. You can get more information about it from United Therapeutics Corporation's website at https://www.unither.com.
Loading...